Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

BLEPHAMIDE S.O.P.

PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM

Standard Dose
0.2%;10%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BLEPHAMIDE S.O.P. is listed in Drugs@FDA under application 087748 (ANDA).

Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM Form and strength OINTMENT;OPHTHALMIC - 0.2%;10% Sponsor ALLERGAN Submission history Latest submission status date: 2001-08-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview BLEPHAMIDE S.O.P. is listed in Drugs@FDA under application 087748 (ANDA). Marketing status: Discontinued Active ingredient PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM Form and strength OINTMENT;OPHTHALMIC - 0.2%;10% Sponsor ALLERGAN Submission history Latest submission status date: 2001-08-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.